Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients

Journal of Neuroimmunology
Raija L P LindbergLudwig Kappos

Abstract

Natalizumab, the most recently approved treatment for relapsing multiple sclerosis (MS) exerts its action through binding to alpha4 integrins. We studied longitudinally gene expression profiles in peripheral blood of MS patients, treated with natalizumab for more than 2 years. The majority of altered genes relates to immune response, signal transduction, adhesion and metabolism. Not only gene expression relevant for T lymphocytes was altered, but also genes regulating B-lymphocyte, neutrophil and erythrocyte functions. Understanding these different gene effects and their interrelationships will provide more insights into additional mechanisms of action of natalizumab and possibly allow better prediction of adverse events.

References

Mar 1, 1991·The Journal of Experimental Medicine·K MiyakeP W Kincade
Oct 1, 1996·Genome Research·U E GibsonP M Williams
Dec 1, 1996·Nature Biotechnology·D J LockhartE L Brown
Nov 2, 2001·Biochemical and Biophysical Research Communications·V YurchenkoM Bukrinsky
Jan 3, 2003·The New England Journal of Medicine·David H MillerUNKNOWN International Natalizumab Multiple Sclerosis Trial Group
Feb 13, 2003·Nucleic Acids Research·Rafael A IrizarryTerence P Speed
Jul 29, 2003·Proceedings of the National Academy of Sciences of the United States of America·John D Storey, Robert Tibshirani
Nov 1, 2003·The International Journal of Biochemistry & Cell Biology·Su Hao Lo
Jun 11, 2005·The New England Journal of Medicine·Annette Langer-GouldDaniel Pelletier
Jun 11, 2005·The New England Journal of Medicine·B K Kleinschmidt-DeMasters, Kenneth L Tyler
Jun 28, 2005·Nucleic Acids Research·Michael PsarrosBeate Sick
Mar 3, 2006·The New England Journal of Medicine·Chris H PolmanUNKNOWN AFFIRM Investigators
Mar 3, 2006·The New England Journal of Medicine·Richard A RudickUNKNOWN SENTINEL Investigators
Apr 25, 2006·Annals of Neurology·Olaf StüveMichael K Racke
Apr 25, 2006·Annals of Neurology·Masaaki NiinoAmit Bar-Or

❮ Previous
Next ❯

Citations

Apr 20, 2010·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Leslie J Marshall, Eugene O Major
Oct 10, 2012·The Pharmacogenomics Journal·V Foti CuzzolaS Marino
Sep 11, 2009·The New England Journal of Medicine·Eugene O Major
May 22, 2013·Clinical & Developmental Immunology·Anna BellizziValeria Pietropaolo
Feb 11, 2010·The Journal of Membrane Biology·Mariana Vaini de FreitasNilson Penha-Silva
Mar 2, 2013·Expert Review of Neurotherapeutics·Annika DeißMathias Buttmann
Mar 26, 2013·Expert Opinion on Biological Therapy·Luisa Klotz, Heinz Wiendl
May 26, 2012·Journal of Neuroimmunology·Alex Sánchez-PlaManuel Comabella
Jun 5, 2012·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Claudia SieversRaija L P Lindberg
Mar 20, 2010·Journal of the Neurological Sciences·Ernst-Wilhelm RadueUNKNOWN SENTINEL Investigators
Sep 16, 2008·Journal of the Neurological Sciences·Ariel MillerTamar Paperna
Oct 3, 2009·Annals of Neurology·Norbert Goebels, Ludwig Kappos
Apr 29, 2009·Annals of Neurology·Joseph R Berger, Sidney Houff
Jun 21, 2013·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Hans H HirschCeline Leboeuf
Apr 19, 2016·Neurology. Neuroimmunology and Neuroinflammation·Maria MeiraRaija L P Lindberg
Feb 3, 2015·Annals of Clinical and Translational Neurology·Jens IngwersenOrhan Aktas
Jun 6, 2013·Clinical & Developmental Immunology·Cillian F De Gascun, Michael J Carr
Jan 16, 2010·MAbs·Joseph R BergerEugene O Major
Aug 9, 2016·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Álvaro Cobo-CalvoSergio Martínez-Yélamos
Oct 1, 2016·Current Infectious Disease Reports·Deanna Saylor, Arun Venkatesan
Nov 14, 2014·Multiple Sclerosis : Clinical and Laboratory Research·Clemens WarnkeBernd C Kieseier
Mar 7, 2014·Multiple Sclerosis : Clinical and Laboratory Research·Maria MeiraRaija L P Lindberg
Feb 6, 2017·Autoimmunity Reviews·Courtney S CasserlyLuc Vallières

❮ Previous
Next ❯

Related Concepts

Related Feeds

B cells: Gene Expression

B lymphocytes are white blood cells that play a role in the adaptive immune system by secreting antibodies. Here is the latest research on gene expression in B cells.

B cell Activation

B cell activation is initiated by the ligation of the B cell receptor with antigen and ultimately results in the production of protective antibodies against potentially pathogenic invaders. Here is the latest research.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

B cell Differentiation

Depending on the signal received through the B cell receptor and other receptors, B cells differentiate into follicular or marginal zone B cells. Here is the latest research pertaining to this differentiation process.